A Double-Blind Randomized Controlled Trial ofN-Acetylcysteine in Cannabis-Dependent Adolescents
- 1 August 2012
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 169 (8), 805-812
- https://doi.org/10.1176/appi.ajp.2012.12010055
Abstract
Objective: Preclinical findings suggest that the over-the-counter supplement N-acetylcysteine (NAC), via glutamate modulation in the nucleus accumbens, holds promise as a pharmacotherapy for substance dependence. The authors investigated NAC as a novel cannabis cessation treatment in adolescents, a vulnerable group for whom existing treatments have shown limited efficacy. Method: In an 8-week double-blind randomized placebo-controlled trial, treatment-seeking cannabis-dependent adolescents (ages 15–21 years; N=116) received NAC (1200 mg) or placebo twice daily as well as a contingency management intervention and brief (<10 minutes) weekly cessation counseling. The primary efficacy measure was the odds of negative weekly urine cannabinoid test results during treatment among participants receiving NAC compared with those receiving placebo, in an intent-to-treat analysis. The primary tolerability measure was frequency of adverse events, compared by treatment group. Results: Participants receiving NAC had more than twice the odds, compared with those receiving placebo, of having negative urine cannabinoid test results during treatment (odds ratio=2.4, 95% CI=1.1–5.2). Exploratory secondary abstinence outcomes favored NAC but were not statistically significant. NAC was well tolerated, with minimal adverse events. Conclusions: This is the first randomized controlled trial of pharmacotherapy for cannabis dependence in any age group to yield a positive primary cessation outcome in an intent-to-treat analysis. Findings support NAC as a pharmacotherapy to complement psychosocial treatment for cannabis dependence in adolescents.Keywords
This publication has 36 references indexed in Scilit:
- N‐Acetylcysteine reduces early‐ and late‐stage cocaine seeking without affecting cocaine taking in ratsAddiction Biology, 2011
- N-Acetylcysteine Reduces Extinction Responding and Induces Enduring Reductions in Cue- and Heroin-Induced Drug-SeekingBiological Psychiatry, 2008
- Services research on adolescent drug treatment. Commentary on “The Cannabis Youth Treatment (CYT) Study: Main findings from two randomized trials”Journal of Substance Abuse Treatment, 2004
- Is the Party Over? Cannabis and Juvenile Psychiatric Disorder: The Past 10 YearsJournal of the American Academy of Child & Adolescent Psychiatry, 2004
- The Cannabis Youth Treatment (CYT) Study: Main findings from two randomized trialsJournal of Substance Abuse Treatment, 2004
- Possible age‐associated bias in reporting of clinical features of drug dependence: epidemiological evidence on adolescent‐onset marijuana useAddiction, 2002
- A graphical sensitivity analysis for clinical trials with non‐ignorable missing binary outcomeStatistics in Medicine, 2002
- Do multiple outcome measures require p-value adjustment?BMC Medical Research Methodology, 2002
- Akaike's Information Criterion in Generalized Estimating EquationsBiometrics, 2001
- Longitudinal Data Analysis for Discrete and Continuous OutcomesBiometrics, 1986